美国VisEn medical www.visenmedical.com 
美国VisEn医学公司作为分子影像领域的先行者，分子影像领域和技术的开发商，该公司在2005年中期开始销售其商品化前期的设备和光学探针产品。我们的产品是第一种能够在动物中真正进行定量、荧光活体三维成像的的光学系统。”，具有专利技术的成像系统和探针 被Massachusetts General Hospital , Harvard Medical School,及其它著名研究机构广泛采用。
该技术具有定量功能并具有广泛的应用范围,应用简述：肿瘤学、免疫性疾病如关节炎模型等、骨病学、肺病学、心血管病学等。
2010年PerkinElmer 收购生物活体分子成像技术公司 VisEn

Pioneering translational in vivo imaging - from research to medicine
With results from genomics and proteomics enhancing our knowledge of the biochemical pathways involved in disease and revealing potential therapeutic targets, there is a growing opportunity to research, understand and measure underlying biological mechanisms and therapeutic responses in vivo.
By developing a unique portfolio of fluorescence-based agents and system solutions that enable scientists to, non-invasively, visualize and quantify biological mechanisms and therapeutic responses deep within the body at the molecular level, VisEn is pioneering a new era of in vivo imaging.
VisEn’s biocompatible fluorescence agents and the company’s breakthrough FMT technology platform for enabling fluorescence-based Quantitative Tomography are already facilitating data generation and translation from profiling to preclinical research and, ultimately, through into clinical trials and medical practice. Today, these powerful imaging solutions are contributing to a deeper understanding of biological mechanisms and therapeutic responses in areas such as inflammatory, cardiovascular, skeletal and pulmonary disease as well as oncology.
Disease
Oncology
Application examples Evaluate disease progression and therapeutic response in tumor models 

Study blood vessel density and angiogenesis in tumor models 

Assess metastases in tumor models over time 

 
Cardiovascular
Application examples Image matrix metalloproteinase (MMP) activity after myocardial infarction 

Image proteolytic activity and micro-calcification in models of atherosclerosis 

 
Skeletal and Inflammatory
Application examples Evaluate disease progression and therapeutic response in inflammatory disease 

Characterize vascular changes and therapeutic response in arthritis models 

Characterize bone remodeling in osteoporosis 

Measure hormone-induced bone growth and steroid-induced bone resorption 

 
Pulmonary
Application examples Visually discriminate, measure and quantify disease severity and therapeutic response in asthma models 
 
User-defined in vivo imaging
Application examples Reporting and labeling using agents designed by the user 

 
The vision to drive science – translation through to the clinic
While VisEn’s first commercial products are intended for in vivo imaging in disease models of small animals used in research and pre-clinical studies, all developments within the company are focused towards developing translational data, and translational solutions.
Close links with leading research, pharmaceutical and clinical institutions guide all VisEn developments, maintaining a focus towards a future of improved clinical disease understanding and treatment.
Development Partnerships - Expertise for customized solutions
VisEn has a broad range of competencies in developing fluorescence agents and in vivo imaging applications — turning initial concepts into validated products and applications. With a tradition of in vivo technology development and fully functional chemistry, biology and animal imaging capabilities, VisEn can work with partners on specific product and application development programs, tailored to their specific research areas. Contact info@visenmedical.com for more information.